These findings, albeit limited, suggest that vascular remodelling, rather than thrombosis, may be the predominant pathogenetic pathway in aPL-positive SLE patients with PAH, but the role of aPL antibodies in this process is yet to be clarified. Here, FASLG is linked to pulmonary arterial hypertension.